Presentation 1Q16
KCM today
LTM 1Q’16 Sales: US$1.9bn(1)
10%
5%
Diapers
Market Cap of US$7.5bn(2)
Bathroom
Tissue
Napkins
Wet Wipes
Feminine &
Adult Care
85%
CP
P&HC
Exports
Market leader
Above average profitability
Strong growth potential
(1)
(2)
CP denotes Consumer Products, P&HC stands for professional and healthcare products. (FX rate 17.29)
As of April 20, 2016.
Solid
financial position
Access to leading technology &
brands
Very efficient production facilities
2
Public
KCM is Well Positioned to Continue
Delivering Industry-Leading Results
Despite notable headwinds on
the last couple of years…
…The successful implementation of
our corporate strategy…
…Allows us to continue delivering results and
positions us to outperform going forward.
Company related
MXN depreciation
Higher raw material prices
Weak consumption
environment
Invested in pricing to
maintain our market
position and grow volume
Operational efficiencies
and cost reduction
initiatives
Continued investing in
product improvements and
capacity expansion

Leading position

Multi-brand & Multi-tier strategy

Extensive product portfolio

Efficient production facilities

Innovative product solutions

Efficient manufacturing and logistics
processes

Above average profitability levels

Robust FCF generation

Solid cash balances
Macro and industry related
Challenging competitive
environment
Product innovation

Nondurable Consumer products industry
resiliency

Gradual recovery of the Mexican economy
3
Public
Business Model
 Operating and administrative cost-reduction
initiatives (rate of savings ~4% of COGS)
Efficient
Operations and
State-of-the-Art
Production Facilities
 Continued focus on production
capacity and investments in
production facilities and
equipment

Wide reach across customer segments
through a sophisticated multi-brand and
multi-price-point strategy
Multi-Brand
and Multi-Tier
Strategies
 Covering economy / value /
premium / super premium
 Efficient supply chain
management
 Innovation across the
broad product portfolio
 Development of new
products and categories
Innovation
and Product
Improvement
 Retailers
Multi-Channel
Strategy
 Constant investment in
production technology
 Partnership with KCC
 Focus on core competencies and key
geographic markets
 Focus on high potential categories
 Opportunistic approach to acquisitions
 Wholesalers
 Price Clubs
 Drugstores
 Concessionaires (away from home)
Continued
Volume and
Market Share
Growth
 Medical Facilities
 Department Stores
 Focus on core products
- Increase penetration, frequency of use and
product mix
4
Public
Historical Financial Performance
(Figures in Ps. million)
$35,000
60.0%
IFRS
32,206
24,702
26,197
29,289
29,678
26.7%
27.7%
29.4%
2011
2012
2013
33,171
29,106
26,732
23,052
21,480
31.1%
2007
30.8%
2008
32.0%
2009
30.8%
2010
Sales (million pesos)
25.7%
27.3%
27.7%
2014
2015
LTM 1Q'16
EBITDA Margin
KCM has increased it´s dividends in real terms over the last 40 years
5
Public
1Q16 Results
1Q'16
1Q'15
CHANGE
$8,728
$7,764
12.4%
GROSS PROFIT
3,436
2,960
16.1%
OPERATING PROFIT
2,050
1,662
23.4%
NET INCOME
1,110
1,000
11.0%
EBITDA
2,459
2,084
18.0%
NET SALES
Sales
 Good growth across all business segments
(volume +6.7% & price/mix +5.7%)
 Improving consumer environment
 Double digit growth for high potential
categories
Profitability
1Q'16
1Q'15
CHANGE pp
GROSS MARGIN
39.4
38.1
1.3
OPERATING MARGIN
23.5
21.4
2.1
NET MARGIN
12.7
12.9
(0.2)
EBITDA MARGIN
28.2
26.8
1.4



Sales (million pesos)
27.3%
27.1%
28.0%
Peso depreciation (~18% YoY)
Lower raw material costs in USD terms
Lower energy costs
Cost reduction program (~Ps. 200million 1Q16)
EBITDA Margin
28.1%
27.7%
33,171
8,027
7,932
8,483
8,728
2Q'15
3Q'15
4Q'15
1Q'16
LTM 1Q'16
6
Public
Outlook 2016
Consumer recovery
Strong brands & position
Targeted price increases and promotions
Headwind in costs: exchange rate
Mitigated by oil derivatives, energy and other raw materials
Strong cost savings plan
Continue to explore new high potential categories
7
Public
Notice to Recipient
The information contained in this presentation is confidential and has been prepared solely for informational purposes. This
presentation does not constitute an offer to sell or a solicitation of an offer to buy any securities of Company.
Actual results may differ materially from those indicated by these forward-looking statements as a result of various factors
and undue reliance should not be placed on these forward-looking statements. We cannot ensure that actual results will
not be materially different from those expressed or implied by these forward-looking statements.
In addition, any forward-looking statements represent our estimates only as of today and should not be relied upon as
representing our estimates as of any subsequent date. While we may elect to update forward-looking statements at some
point in the future, we specifically disclaim any obligation to do so, even if our estimates change.
8
Public